We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $189M Turnover 22.11%
1-Year Est. Return 67.72%
This Fund
S&P 500
This Quarter Est. Return
+5.62%
1 Year Est. Return
+67.72%
3 Year Est. Return
+169.37%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$262M
AUM Growth
+$10.7M
Cap. Flow
+$4.02M
Cap. Flow %
1.54%
Top 10 Hldgs %
69.6%
Holding
162
New
14
Increased
11
Reduced
9
Closed
31
Avg Time Held
1.2 years
Top 10 Avg Time Held
1.3 years
Top 20 Avg Time Held
1 year

Top Buys

Rank Stock Value
1
DCGO icon
DocGo
DCGO
+$4.26M
2
CLOZ icon
Panagram BBB-B CLO ETF
CLOZ
+$3.14M
3
GCVRZ
Sanofi Contingent Value Rights
GCVRZ
+$3M
4
MOR icon
MorphoSys AG American Depositary Shares
MOR
+$2.66M
5
UTHR icon
United Therapeutics
UTHR
+$2.06M

Top Sells

Rank Stock Value
1
AGAC.WS
African Gold Acquisition Corp Warrants
AGAC.WS
+$5.18M
2
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$3.42M
3
SNY icon
Sanofi
SNY
+$3.02M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$2.8M
5
FIP icon
FTAI Infrastructure
FIP
+$1.57M

Sector Composition

Rank Sector Weight
1 Materials 34.61%
2 Healthcare 25.56%
3 Financials 13.62%
4 Miscellaneous 7.72%
5 Industrials 6.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ICLO icon
26
Invesco AAA CLO Floating Rate Note ETF
ICLO
$604M
$1.98M 0.76%
+77,377
New +$1.98M
2023 Q3
0 quarters
CVE icon
27
Cenovus Energy
CVE
$60.1B
$1.98M 0.76%
95,000
– –
2022 Q2
5 quarters
TWLVW icon
28
DELISTED
Twelve Seas Investment Company II Warrant
TWLVW
$1.92M 0.73%
166,666
– –
2021 Q4
7 quarters
INZY icon
29
DELISTED
Inozyme Pharma
INZY
$1.91M 0.73%
454,008
+234,008
+106% +$1.19M
2023 Q1
2 quarters
EXE icon
30
Expand Energy Corp
EXE
$21.7B
$1.73M 0.66%
20,000
– –
2022 Q2
5 quarters
OVV icon
31
Ovintiv
OVV
$18.9B
$1.67M 0.64%
35,000
– –
2022 Q2
5 quarters
JAAA icon
32
Janus Henderson AAA CLO ETF
JAAA
$32.1B
$1.58M 0.6%
+31,432
New +$1.57M
2023 Q3
0 quarters
AB icon
33
AllianceBernstein
AB
$3.19B
$1.5M 0.57%
49,500
– –
2021 Q4
7 quarters
WHWK icon
34
Whitehawk Therapeutics
WHWK
$169M
$1.28M 0.49%
265,000
+4,000
+2% +$23.3K
2022 Q2
5 quarters
MOS icon
35
The Mosaic Company
MOS
$6.01B
$1.25M 0.48%
35,000
– –
2022 Q2
5 quarters
VRTX icon
36
Vertex Pharmaceuticals
VRTX
$128B
$1.04M 0.4%
3,000
– –
2021 Q4
7 quarters
RHP icon
37
Ryman Hospitality Properties
RHP
$8.69B
$999K 0.38%
12,000
-400
-3% -$35.3K
2021 Q4
7 quarters
MDLZ icon
38
Mondelez International
MDLZ
$81.7B
$972K 0.37%
14,000
– –
2021 Q4
7 quarters
TVTX icon
39
Travere Therapeutics
TVTX
$4.74B
$897K 0.34%
+100,317
New +$1.42M
2023 Q3
0 quarters
PTGX icon
40
Protagonist Therapeutics
PTGX
$8.27B
$873K 0.33%
+52,368
New +$1.02M
2023 Q3
0 quarters
XENE icon
41
Xenon Pharmaceuticals
XENE
$3.25B
$815K 0.31%
23,866
– –
2021 Q4
7 quarters
ABBV icon
42
AbbVie
ABBV
$503B
$751K 0.29%
5,037
– –
2021 Q4
7 quarters
DD icon
43
DuPont de Nemours
DD
$17.7B
$741K 0.28%
7,911
– –
2021 Q4
7 quarters
KMB icon
44
Kimberly-Clark
KMB
$34.8B
$725K 0.28%
6,000
– –
2021 Q4
7 quarters
ACLX icon
45
DELISTED
Arcellx
ACLX
$718K 0.27%
20,000
-20,000
-50% -$690K
2023 Q1
2 quarters
ABEO icon
46
Abeona Therapeutics
ABEO
$253M
$674K 0.26%
160,000
– –
2022 Q4
3 quarters
FAZEW
47
DELISTED
FaZe Holdings Inc. Warrant
FAZEW
$671K 0.26%
58,321
– –
2023 Q2
1 quarter
ALKS icon
48
Alkermes
ALKS
$6.79B
$630K 0.24%
22,491
-44,509
-66% -$1.3M
2023 Q2
1 quarter
EOLS icon
49
Evolus
EOLS
$474M
$622K 0.24%
68,066
+47,566
+232% +$427K
2023 Q1
2 quarters
CTVA icon
50
Corteva
CTVA
$8.67B
$592K 0.23%
11,563
– –
2021 Q4
7 quarters
1
2
3 4 5

Similar funds

SCA
Sander Capital Advisors Seattle, Washington $189M AUM 13.06% 1-Year Est. Return
FI
FWG Investments Lexington, Kentucky $189M AUM 18.47% 1-Year Est. Return
MFS
Madrid Financial Services Manhattan Beach, California $189M AUM 30.12% 1-Year Est. Return
FRA
FFG Retirement Advisors Centennial, Colorado $189M AUM 16.39% 1-Year Est. Return
CAM
Councilmark Asset Management Knoxville, Tennessee $189M AUM 26.93% 1-Year Est. Return
BAG
Bauman Advisory Group Las Vegas, Nevada $189M AUM
SHC
SALT Holding Corp Wilmington, Delaware $189M AUM 34.63% 1-Year Est. Return
HC
Hara Capital Bellevue, Washington $190M AUM 42.56% 1-Year Est. Return

David M. Knott Jr's Q3 2023 Portfolio in Review

As of Q3 2023, David M. Knott Jr held 162 positions worth $262M, up 4.2% from $251M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

David M. Knott Jr's Q3 2023 filing shows 14 new, 11 increased, 9 reduced and 31 closed positions. Its largest new stake was Panagram BBB-B CLO ETF: 121,032 shares worth $3.16M. The largest sale was African Gold Acquisition Corp Warrants, an estimated $5.18M.

By sector, the portfolio is most concentrated in Materials at 35% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.

  • David M. Knott Jr's largest Q3 2023 buy was Panagram BBB-B CLO ETF: 121,032 shares worth $3.16M.
  • David M. Knott Jr added most to DocGo in Q3 2023, an estimated $4.26M increase.
  • David M. Knott Jr's biggest Q3 2023 reduction was Seres Therapeutics, cutting an estimated $1.53M.
  • David M. Knott Jr fully exited African Gold Acquisition Corp Warrants in Q3 2023, selling an estimated $5.18M.
  • David M. Knott Jr's ten largest holdings make up 70% of its $262M portfolio in Q3 2023.
  • David M. Knott Jr opened 14 new positions and closed 31 in Q3 2023.
  • David M. Knott Jr's portfolio value rose 4.2% quarter-over-quarter to $262M.

Based on David M. Knott Jr's 13F filing for Q3 2023, filed 13 Nov 2023.